
Sign up to save your podcasts
Or


Promo: Big-cap biopharma could come knocking if Juno Therapeutics’ next-generation CAR-T is safer than its competitors, and Medtronic's already investing billions in Mazor Robotics, a maker of surgical robots. Sponsored link: http://www.casper.com/fool Code: fool.
By The Motley FoolPromo: Big-cap biopharma could come knocking if Juno Therapeutics’ next-generation CAR-T is safer than its competitors, and Medtronic's already investing billions in Mazor Robotics, a maker of surgical robots. Sponsored link: http://www.casper.com/fool Code: fool.